Chewing Gum Cuts HPV Levels in Cancer Study

University of Pennsylvania researchers tested an experimental gum that reduced HPV and cancer-linked bacteria in samples from head and neck cancer patients.

Updated on Nov. 16, 2026 in Cancer

Pale green chewing gum pellet beside a small glass vial of amber liquid on a clean laboratory counter, with soft daylight from windows behind.
University of Pennsylvania researchers reported that an experimental chewing gum cut HPV levels by 80 percent in oral rinse samples from head and neck cancer patients. AI Illustration. Upload story photo >

Live Poll

Would you be willing to try a chewing gum to reduce HPV?

Researchers at the University of Pennsylvania reported that an experimental chewing gum reduced HPV levels by 80 percent in oral rinse samples and 93 percent in saliva samples from cancer patients with detectable HPV. The findings were published in Scientific Reports.

Why it matters

The gum was developed as a potentially low-cost, accessible approach to reducing HPV and cancer-associated bacteria in head and neck cancer. Head and neck cancers remain a major burden, and the team notes that additional research is needed before any clinical use.

The study analyzed saliva and oral rinse samples from 44 head and neck cancer patients, reporting HPV reductions of 93 percent and 80 percent respectively, though the tests used gum extracts rather than the gum itself. Whether these lab reductions translate into patient benefit has not been established.

The players

University of Pennsylvania

A private Ivy League research university in Philadelphia whose researchers conducted the study on the experimental chewing gum.

The details

The gum used two formulations based on bean powder from lablab beans: one containing the plant compound Flt3 receptor-interacting lectin to target HPV particles, and one containing the peptide protegrin-1 to target the bacteria Porphyrromonas gingivalis and Fusobacterium nucleatum. The gum also spared some healthy bacteria living in the mouth.

Timeline

  1. Study published in Scientific Reports in 2026.

  2. Researchers plan to move the technology into human clinical trials.

Big Picture

Roughly 60 to 70 percent of oropharyngeal cancers are linked to HPV, and the new gum approach targets that viral driver directly in the mouth. It represents an attempt to intervene at the site of infection rather than only treating established tumors.

For now the gum remains experimental and is not available to patients. Head and neck cancer patients and people concerned about HPV should continue to follow established screening and treatment guidance from their clinicians.

The takeaway

Lab results for an HPV-targeting gum are promising but preliminary, and the next step is human testing. Readers should rely on current medical advice while this research continues.

Further reading

Explore more on Cancer research and treatment developments.

Live Poll

Would you be willing to try a chewing gum to reduce HPV?